https://doi.org/10.1038/s41586-019-1906-8 .https://www. ncbi.nlm.nih.gov/pubmed/31942077 . Poran, A., Scherer, J., Bushway, M.E., Besada, R., Balogh, K.N., Wanamaker, A., Williams, R.G., Prabhakara, J., Ott, P.A., Hu-Lieskovan, S., et al. (2020). Combined TCR repertoire proﬁles and blood cell phenotypes predict mela- noma patient response to personalized neoantigen therapy plus anti-PD-1.Cell Rep. Med.